Erythropoietin Treatment in Patients With Systolic Left Ventricular Dysfunction, Mild Anemia and Normal Renal Function

• Status: Unknown status
• Trial end date: 2008-01-01
• Target enrollment: 0
• Participant gender: All

Summary

Erythropoietin Treatment in Patients with systolic left ventricular dysfunction, mild anemia and normal renal function

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Rabin Medical Center
• Treatments: Epoetin Alfa

Criteria

Inclusion Criteria:

• Ischemic heart disease

• Systolic lv dysfunction

• Mild anemia

• Normal renal function

• Stable condition

Exclusion Criteria:

• Pregnancy

• Unstable condition

• Under 18 years old